0 followers
Olaris aims to fundamentally change how diseases are diagnosed and treated. With their pioneering metabolomics platform and machine learning algorithms, they produce personalized “Biomarkers of Response” (BoR) to readily differentiate drug responders (R) from non-responders (NR).
Elizabeth O'Day
Immunome
2 followers
Amgen
202 followers
Miami Foundation
2 followers
Capricor Therapeutics
1 follower
Elicio Therapeutics
1 follower
Artiva Biotherapeutics
1 follower
Thermo Fisher Scientific
160 followers
Regeneron
92 followers
Publicis Sapient
47 followers
Roivant Sciences
56 followers
FactSet
36 followers
Explore companies